This page is not available in English

You must accept marketing cookies to share the page by mail

Update consent

Share by mail

Your email: Recipient's email:

Click here to see the Danish page '▼Xeljanz® (tofacitinib): Øget risiko for alvorlige kardiovaskulære hændelser og maligniteter ved brug af tofacitinib sammenlignet med TNF-alfa-hæmmere' Go to English frontpage